Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration

Blood

Volumn 114, Issue 7, 2009, Pages 1366-1373

  Ghosh, Manik C ^a   Collins, Gary D ^a   Vandanmagsar, Bolormaa ^a   Patel, Kalpesh ^a   Brill, Margaret ^a   Carter, Arnell ^a   Lustig, Ana ^a   Becker, Kevin G ^a   Wood III, William W ^a   Emeche, Chineye D ^a   French, Amanda D ^a   O'Connell, Michael P ^a   Xu, Mai ^a   Weeraratna, Ashani T ^a   Taub, Dennis D ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; PROTEIN KINASE C; STROMAL CELL DERIVED FACTOR 1; WNT5A PROTEIN; CXCL12 PROTEIN, HUMAN; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, HUMAN; CXCR4 PROTEIN, MOUSE; ONCOPROTEIN; WNT PROTEIN; WNT5A PROTEIN, HUMAN; WNT5A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THYMOMA; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL MOTION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; HUMANS; MICE; MICE, MUTANT STRAINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION; WNT PROTEINS;

EID: 70349310357     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-08-175869     Document Type: Article

References (26)

1. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol. 1994;1:229-246.
2. Marelli-Berg FM, Cannella L, Dazzi F, Mirenda V. The highway code of T cell trafficking. J Pathol. 2008;214:179-189.
3. Kim CH. The greater chemotactic network for lymphocyte trafficking: chemokines and beyond. Curr Opin Hematol. 2005;12:298-304.
4. Taub DD. Chemokine-leukocyte interactions: the voodoo that they do so well. Cytokine Growth Factor Rev. 1996;7:355-376.
5. Lee B, Doranz BJ, Ratajczak MZ, Doms RW. An intricate web: chemokine receptors, HIV-1 and hematopoiesis. Stem Cells. 1998;16:79-88. (Pubitemid 28158721)
6. Nagasawa T, Tachibana K, Kishimoto T. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin Immunol. 1998;10:179-185. (Pubitemid 28347034)
7. Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004;35:233-245. (Pubitemid 40585309)
8. + T-cells. J Immunol. 2001;167:3064-3073.
9. Morin PJ, Weeraratna AT. Wnt signaling in human cancer. Cancer Treat Res. 2003;115:169-187.
10. Weeraratna AT. A Wnt-er wonderland: the complexity of Wnt signaling in melanoma. Cancer Metastasis Rev. 2005;24:237-250.
11. Wu B, Crampton SP, Hughes CC. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity. 2007;26:227-239. (Pubitemid 46329437)
12. Witze ES, Litman ES, Argast GM, Moon RT, Ahn NG. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science. 2008;320:365-369. (Pubitemid 351555657)
13. Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002;1:279-288. (Pubitemid 41039152)
14. Hsieh JC, Kodjabachian L, Rebbert ML, et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature. 1999;398:431-436. (Pubitemid 29180376)
15. Lisovsky M, Itoh K, Sokol SY. Frizzled receptors activate a novel JNK-dependent pathway that may lead to apoptosis. Curr Biol. 2002;12:53-58. (Pubitemid 34063353)
16. Dissanayake SK, Wade M, Johnson CE, et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem. 2007;282:17259-17271. (Pubitemid 47093253)
17. Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology. 2007;106:499-506. (Pubitemid 46662215)
18. Luo Y, Cai J, Xue H, Mattson MP, Rao MS. SDF1α/CXCR4 signaling stimulates β-catenin transcriptional activity in rat neural progenitors. Neurosci Lett. 2006;398:291-295. (Pubitemid 43673701)
19. Tickenbrock L, Schwable J, Strey A, et al. Wnt signaling regulates transendothelial migration of monocytes. J Leukocyte Biol. 2006;79:1306-1313. (Pubitemid 44835566)
20. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation. J Cell Biol. 2003;162:899-908. (Pubitemid 37087729)
21. Roman-Gomez J, Jimenez-Velasco A, Cordeu L, et al. WNT5A, a putative tumor suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukemia. Eur J Cancer. 2007;43:2736-2746. (Pubitemid 350161849)
22. Ying J, Li H, Chen YW, Srivastava G, Gao Z, Tao Q. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood. 2007;110:4130-4132. (Pubitemid 350248475)
23. Nygren MK, Dosen G, Hystad ME, Stubberud H, Funderud S, Rian E. Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol. 2007;136:400-413. (Pubitemid 46046298)
24. Dorfman DM, Greisman HA, Shahsafaei A. Loss of expression of the WNT/β-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas. Am J Pathol. 2003;162:1539-1544. (Pubitemid 36512836)
25. Maeda H, Shiraishi A. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol. 1996;156:73-78. (Pubitemid 3024752)
26. Ray N, Doms RW. HIV-1 coreceptors and their inhibitors. Curr Top Microbiol Immunol. 2006;303:97-120.